AXG revenueFY2026$28.05M
- FY YoY
- +895.0%
AXG revenue was $28.05M for fiscal 2026 (ended Mar 31, 2026), up 895.0% from fiscal 2025. It rose in 2 of the last 4 fiscal years. Fiscal 2026 is the highest of the 5 fiscal years on file.
For fiscal 2026 (ended Mar 31, 2026), Solowin Holdings reported $28.05M of revenue and -$13.29M of net income.
AXG revenue was $28.05M for fiscal 2026 (ended Mar 31, 2026), up 895.0% from fiscal 2025. It rose in 2 of the last 4 fiscal years. Fiscal 2026 is the highest of the 5 fiscal years on file.
AXG net income was -$13.29M for fiscal 2026 (ended Mar 31, 2026), compared with -$8.54M in fiscal 2025.
AXG diluted EPS was -$0.11 for fiscal 2026 (ended Mar 31, 2026).
AXG free cash flow was -$15.52M for fiscal 2026 (ended Mar 31, 2026), compared with -$1.15M in fiscal 2025.
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $28.05M | $2.82M | $4.29M | $4.45M | $3.26M |
| Selling, general and admin | $1.69M | $1.38M | $383.0K | $1.39M | $1.07M |
| Operating income | - | - | $3.0K | $61.0K | $196.0K |
| Interest expense | - | $5.0K | - | - | $229.0K |
| Pre-tax income | -$13.29M | -$8.52M | -$4.40M | $1.35M | -$979.0K |
| Income tax | - | $19.0K | $155.0K | - | - |
| Net income | -$13.29M | -$8.54M | -$4.56M | $1.35M | -$979.0K |
| EPS, basic | -$0.11 | -$0.53 | -$0.33 | $0.11 | -$0.09 |
| EPS, diluted | -$0.11 | -$0.53 | -$0.33 | $0.11 | -$0.09 |
| Diluted shares | 124.9M | 16.1M | 13.7M | 12.0M | 10.4M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|---|
| Cash and equivalents | $16.80M | $3.84M | $2.14M | $7.51M | $8.07M |
| Receivables | - | $211.0K | $3.55M | $309.0K | - |
| Current assets | $37.66M | $9.66M | $12.79M | $9.72M | - |
| Goodwill | $47.0K | - | - | - | - |
| Total assets | $50.71M | $12.31M | $15.40M | $10.23M | $9.46M |
| Current liabilities | $24.36M | $7.49M | $6.04M | $6.79M | - |
| Short-term debt | - | $5.0K | - | - | - |
| Total liabilities | $25.59M | $7.58M | $6.48M | $6.89M | $7.46M |
| Shareholders' equity | $25.17M | $4.73M | $8.92M | $3.34M | $2.00M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|---|
| Operating cash flow | -$15.34M | -$1.06M | -$5.61M | -$443.0K | -$5.74M |
| Capital expenditures | $186.0K | $88.0K | $141.0K | $8.0K | $17.0K |
| Free cash flow | -$15.52M | -$1.15M | -$5.75M | -$451.0K | -$5.75M |
| Investing cash flow | $4.45M | $287.0K | -$1.38M | $225.0K | $114.0K |
| Financing cash flow | $21.07M | $2.38M | $6.72M | -$341.0K | $1.46M |
| Stock-based compensation | $3.22M | $3.31M | $3.81M | - | - |
| Depreciation and amortization | $131.0K | $81.0K | $23.0K | - | - |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue growth, YoY | 895.0% | -34.3% | -3.6% | 36.8% | - |
| Operating margin | - | - | 0.1% | 1.4% | 6.0% |
| Net margin | -47.4% | -302.9% | -106.2% | 30.3% | -30.1% |
| Free cash flow margin | -55.3% | -40.6% | -134.0% | -10.1% | -176.8% |
| Return on equity | -52.8% | -180.5% | -51.1% | 40.4% | -48.9% |
| Return on assets | -26.2% | -69.4% | -29.6% | 13.2% | -10.3% |
| Current ratio | 1.55 | 1.29 | 2.12 | 1.43 | - |
Source: XBRL data Solowin Holdings files with the SEC, latest filing dated Aug 3, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| AXG | $28.05M | +895.0% | -$13.29M | -47.4% | $1.4M |
| MS | $80.16B | +16.2% | $20.45B | 25.5% | $284.96B |
| GS | $69.70B | +18.7% | $22.17B | 31.8% | $249.73B |
| BLK | $28.54B | +24.7% | $6.91B | 24.2% | $182.05B |
| SCHW | $26.02B | +20.3% | $10.10B | 38.8% | $158.22B |
| CME | $6.97B | +9.0% | $4.43B | 63.5% | $109.49B |
| ICE | $14.05B | +12.1% | $4.16B | 29.6% | $96.27B |
| HOOD | $5.08B | +20.9% | $1.98B | 39.0% | $72.86B |
| NDAQ | $9.15B | +11.5% | $2.08B | 22.8% | $59.44B |